Drugs for Autism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 408)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
2 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
3 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
4 |
|
Atomoxetine |
Approved |
Phase 4 |
|
82248-59-7, 83015-26-3 |
54841 |
Synonyms:
(-)-Tomoxetine
Atomoxetina
Atomoxetine
Atomoxetine HCL
Atomoxetine hydrochloride
HCL, Atomoxetine
Hydrochloride, atomoxetine
LY-139603
LY-139603|Strattera®
N-Methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
Strattera
|
Tomoxetina
Tomoxetina [Spanish]
Tomoxetine
Tomoxetine [INN]
TOMOXETINE HCL
Tomoxetine hydrochloride, (-)-isomer
Tomoxetine hydrochloride, (+-)-isomer
Tomoxetine hydrochloride, (+)-isomer - T351671
Tomoxetinum
Tomoxetinum [Latin]
|
|
5 |
|
Milnacipran |
Approved, Investigational |
Phase 4 |
|
92623-85-3, 96847-54-0 |
11622909 65833 6917779 |
Synonyms:
(-)-Milnacipran
(+-)-Milnacipran
(1S,2R)-MILNACIPRAN
1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCL
1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCL
F 2207
F 2695
F2207
F-2695
F-2695|Fetzima®
Fetzima
|
Ixel
Levomilnacipran
Midalcipran
Milnacipran
Milnacipran hydrochloride
Milnacipranum
Milnacipranum [latin]
Savella
Savella®
Toledomin
|
|
6 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
7 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 Propylpentanoic acid
2-N-PROPYL-4-PENTENOIC ACID
2-N-Propyl-N-valerate
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-Propylpentanoic acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-Propylvaleric acid
44089
4-Heptanecarboxylate
4-Heptanecarboxylic acid
A-44090
A-44090|Depakote®|Epilim®|valproate sodium
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acido valproico
ácido valproico
Acidum valproicum
Alti-valproic
Apo-divalproex
Apo-valproic
Apo-valproic syrup
Avugane
Baceca
Calcium valproate
Calcium, valproate
Convulex
Convulsofin
Delepsine
Depacon
Depakene
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Deproic
Di-N-propylacetate
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-n-propylessigsäure
Dipropyl acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DOM-divalproex
Dom-valproate
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
Epiject i.v.
Epilex
Epilim
|
Epival
Epival er
Ergenyl
Gen-divalproex
Kyselina 2-propylvalerova
LEP321
Magnesium valproate
Med valproic
Mylproin
Myproate
Myproic acid
N-Dipropylacetic acid
N-DPA
Novo-divalproex
Novo-valproic
Novo-valproic - ecc
Novo-valproic soft gel cap
NSC-93819
Nu-valproic
PEAC
Penta-valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
Ratio-valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
Sandoz valproic
Savicol
Semisodium valproate
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
Sprinkle
STAVZOR
Valcote
Valparin
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
VALPROIC ACID
Valproic acid usp
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
|
|
8 |
|
Methylphenidate |
Approved, Investigational |
Phase 4 |
|
113-45-1 |
4158 |
Synonyms:
4311/B Ciba
alpha-Phenyl-2-piperidineacetate methyl ester
alpha-Phenyl-2-piperidineacetic acid methyl ester
a-Phenyl-2-piperidineacetate methyl ester
a-Phenyl-2-piperidineacetic acid methyl ester
Calocain
Celltech brand OF methylphenidate hydrochloride
Centedein
Centedrin
Centedrine
Centredin
Cephalon brand OF methylphenidate hydrochloride
Concerta
Concerta®|Jornay PM® (a.k.a. HLD200)|Ritalin®
COTEMPLA XR-ODT
Daytrana
D-Methylphenidate HCL
Equasym
Focalin
Focalin XR
Hydrochloride, methylphenidate
Mallinckrodt brand OF methylphenidate hydrochloride
Meridil
Metadate
Metadate CD
Metadate ER
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl alpha-phenyl-alpha-2-piperidinylacetic acid
Methyl a-phenyl-a-(2-piperidyl)acetate
Methyl a-phenyl-a-(2-piperidyl)acetic acid
Methyl a-phenyl-a-2-piperidinylacetate
Methyl a-phenyl-a-2-piperidinylacetic acid
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenidylacetic acid
methyl phenyl(piperidin-2-yl)acetate
Methyl phenyl(piperidin-2-yl)acetic acid
|
Methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetic acid
Methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetic acid
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate HCL
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidic acid
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MPH
Novartis brand 1 OF methylphenidate hydrochloride
Novartis brand 2 OF methylphenidate hydrochloride
Phenidylate
Plimasine
PMS-Methylphenidate
Riphenidate
Ritalin
Ritalin hydrochloride
Ritalin LA
Ritalin SR
Ritaline
Ritalin-SR
Ritcher Works
Tsentedrin
Α-phenyl-2-piperidineacetate methyl ester
Α-phenyl-2-piperidineacetic acid methyl ester
|
|
9 |
|
Olanzapine |
Approved, Investigational |
Phase 4 |
|
132539-06-1 |
135398745 4585 |
Synonyms:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-B][1,5]BENZODIAZEPINE
ARKOLAMYL
Lanzac
LY170053
LY-170053
LY-170053|Zyprexa®
Olansek
OLANZAPIN
Olanzapina
|
OLANZAPINE
Olanzapine pamoate
Olanzapinum
Symbyax
ZALASTA
Zolafren
Zydis
Zyprexa
Zyprexa intramuscular
Zyprexa zydis
|
|
10 |
|
Guanfacine |
Approved, Investigational |
Phase 4 |
|
29110-47-2 |
3519 |
Synonyms:
Estulic
Estulic®|Intuniv®|Tenex®
ETC141
GUANFACINA
GUANFACINE
Guanfacine hydrochloride
Guanfacine monohydrochloride
|
GUANFACINUM
Hydrochloride, guanfacine
INTUNIV
Monohydrochloride, guanfacine
SPD 503
Tenex
|
|
11 |
|
Inositol |
Approved, Investigational, Withdrawn |
Phase 4 |
|
87-89-8 |
|
Synonyms:
(1R,2R,3S,4S,5R,6S)-Cyclohexane-1,2,3,4,5,6-hexol
1,2,3,4,5,6-HEXAHYDROXY-cyclohexane
1,2,3,5/4,6-cyclohexanehexol
1D-Myo-inositol
1l-Myo-inositol
Bios I
cis-1,2,3,5-trans-4,6-cyclohexanehexol
CYCLOHEXANEHEXOL
Cyclohexitol
Dambose
D-Myo-inositol
I-inositol
Inosital
Inosite
Inositol
Ins
|
Iso-inositol
L-myo-Inositol
Meat sugar
meso-Inositol
MI
Myo inositol
Myoinosite
myo-inositol
Myoinositol
NSC-25142
NSC-404118
NSC-55551
NSC-8101
Phaseomannite
Rat antispectacled eye factor
Vitamin b8
|
|
12 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446 |
Synonyms:
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
Aclonium
Apo gabapentin
Apo-gabapentin
ApoGabapentin
CI 945
CI 945|Go 3450|GOE 2450|GOE 3450|Neurontin®
CI-945
Convalis
DM-1796
GABAPENTIN
GABAPENTIN GR
Gabapentin hexal
Gabapentin ratiopharm
Gabapentin stada
Gabapentina
Gabapentine
|
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GO 3450
GOE 2450
GOE 3450
GOE-3450
Gralise
Neurontin
Novo gabapentin
Novo-gabapentin
NovoGabapentin
Novo-gabapentine
PMS-Gabapentin
|
|
13 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
Abilify
ABILIFY MAINTENA
ABILIFY MAINTENA KIT
ABILIFY MYCITE KIT
Abilify®|Aripiprex®|Aristada® (aripiprazole lauroxil)|OPC 14597|OPC-14597
Abilitat
Aripiprazol
|
ARIPIPRAZOLE
Aripiprazolum
ARIPIPREX
OPC 14597
OPC 31
OPC-14597
OPC-31
|
|
14 |
|
Risperidone |
Approved, Investigational |
Phase 4 |
|
106266-06-2 |
5073 |
Synonyms:
Belivon
Buspirone
Consta, risperdal
LY03004
LY-03004
N05AX08
Okedi®|R-64-766|R-64766|Risperdal®
PERSERIS KIT
R-64,766
R-64766
R-64-766
RCN3028
RCN-3028
Rispen
Risperdal
Risperdal consta
RISPERDAL CONSTA LONG ACTING
|
RISPERDAL M
Risperdal m-tab
RISPERDAL QUICKLET
RISPERDONE
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Rispéridone
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
Sequinan
Spiron
|
|
15 |
|
Choline |
Approved, Nutraceutical |
Phase 4 |
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(2-HYDROXYETHYL)TRIMETHYLAZANIUM
(beta-Hydroxyethyl)trimethylammonium
2-HYDROXYETHYL-TRIMETHYL-AMMONIUM
2-HYDROXYETHYL-TRIMETHYL-AZANIUM
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
CHOLINE
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
|
CHOLINE ion
Choline O sulfate
Choline O-sulfate
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
Trimethylethanolamine
Vidine
Vitamin J
|
|
16 |
|
Melatonin |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
73-31-4 |
896 |
Synonyms:
[<sup>3</sup>H]-melatonin|[<sup>3</sup>H]MLT
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} acetamide
3-(2-Acetamidoethyl)-5-methoxyindole
5-Methoxy-N-acetyltryptamine
BCI-049
Circadin
Circadin®|MLT
GENERAL NUTRIT
HEALTH AID
HEIDADOUPPI
ICENIA
J5.258B
LIFE EXT
MELAPURE
Melatol
Melatonin
Melatonin (synth.) standard-grade
Melatonin (synth.) ultra-pure
Melatonina
Melatonine
Mélatonine
Melovine
MLT
|
MT6
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-acetamide
N-Acetyl-5-methoxytryptamine
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine melatonine
NATROL
NATURE'S BLEND
NATURES BOUNTY
NSC-113928
NSC-56423
QUALITY HEALTH
Regulin
S.GARD
TRAVELAG
VESPRO
VYTALONIN
|
|
17 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
18 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
19 |
|
Immunoglobulins, Intravenous |
|
Phase 4 |
|
|
|
20 |
|
gamma-Globulins |
|
Phase 4 |
|
|
|
21 |
|
Rho(D) Immune Globulin |
|
Phase 4 |
|
|
|
22 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
23 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
24 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
25 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
26 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
27 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
28 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
29 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
30 |
|
Antiemetics |
|
Phase 4 |
|
|
|
31 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
32 |
|
Insulin, Globin Zinc |
|
Phase 4 |
|
|
|
33 |
|
Insulin |
|
Phase 4 |
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
34 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
35 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
36 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
37 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
38 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
39 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
40 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
41 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
42 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 4 |
|
|
|
43 |
|
Lisdexamfetamine Dimesylate |
|
Phase 4 |
|
|
|
Synonyms:
ELVANSE
ELVANSE ADULT
LISDEXAMFETAMINE DIMESYLATE
LISDEXAMFETAMINE DIMETHANESULFONATE
LISDEXAMFETAMINE MESILATE
|
NRP104
NRP-104
SPD489
SPD-489
VYVANSE
|
|
44 |
|
Protective Agents |
|
Phase 4 |
|
|
|
45 |
|
Antioxidants |
|
Phase 4 |
|
|
|
46 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
47 |
|
Everolimus |
Approved |
Phase 2, Phase 3 |
|
159351-69-6 |
70789204 6442177 |
Synonyms:
001, RAD
40-O-(2-Hydroxyethyl)-rapamycin
42-O-(2-HYDROXYETHYL)RAPAMYCIN
Afinitor
AFINITOR DISPERZ
Afinitor®|Certican®|RAD-001|RAD001|rapamycin, 42-O-(2-hydroxyethyl)-|Zortress®
Certican
EVEROLIMUS
évérolimus
RAD 001
|
RAD 666
RAD, SDZ
RAD001
RAD-001
RAD-666
SDZ RAD
SDZ-RAD
VOTUBIA
ZORTRESS
|
|
48 |
|
Galantamine |
Approved |
Phase 3 |
|
357-70-0, 1953-04-4 |
9651 |
Synonyms:
(-)-GALANTHAMINE
ACUMOR XL
CONSION XL
ELMINO XL
Galantamin
Galantamina
Galantamine
Galanthamine
Galanthamine hydrobromide
galanthamine|Razadyne®
GALSYA XL
GALZEMIC XL
GATALIN XL
GAZYLAN XL
|
Jilkon
LOTPROSIN XL
LUVENTA XL
Lycoremin
Lycoremine
Nivalin
Nivaline
NSC-100058
Ortho mcneil neurologics brand OF galantamine
Ortho-mcneil neurologics brand OF galantamine
Razadyne
Reminyl
REMINYL XL
ZEEBRAL XL
|
|
49 |
|
Histamine |
Approved, Investigational |
Phase 3 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
|
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Eramin
Ergamine
Ergotidine
Histamine
HSM
Imidazole-4-ethylamine
NSC-33792
Β-imidazolyl-4-ethylamine
|
|
50 |
|
Hydroxocobalamin |
Approved |
Phase 2, Phase 3 |
|
13422-51-0 |
15589840 44475014 |
Synonyms:
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
ALPHAREDISOL
Axlon
Ciplamin H
Cobalex
Cobalin H
COBALIN-H
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Codroxomin
CYANOKIT
Docclan
Docelan
Docevita
Droxomin
Ducobee hy
Duradoce
|
Duralta-12
HEPAVIT
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxo-cobalamin
HYDROXOCOBALAMIN ACETATE
HYDROXOCOBALAMIN ANHYDROUS
Hydroxocobalamine
HYDROXOCOBALAMINUM ANHYDROUS
HYDROXOCOBEMINE
Hydroxomin
Hydroxycobalamin
MEGAMILBEDOCE
NEO-CYTAMEN
OH-CBL
Vitamin b-12b
|
|
Interventional clinical trials:
(show top 50)
(show all 1389)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multinational, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Aripiprazole in Asian Pediatric Patients With Autism Spectrum Disorder and Behavior Problems |
Unknown status |
NCT02069977 |
Phase 4 |
Aripiprazole |
2 |
Intranasal Dexmedetomidine vs Oral Triclofos Sodium Sedation for Children With Autism Undergoing Electroencephalograms - A Randomized Controlled Trial. |
Unknown status |
NCT04270708 |
Phase 4 |
Dexmedetomidine;Triclofos 100 MG/ML |
3 |
Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism |
Unknown status |
NCT01098383 |
Phase 4 |
Acetyl-Choline Esterase Inhibitors and Choline supplements;Indistinguishable placebo tablets, matching both donepezil and choline |
4 |
A Phase IV, Single-site, Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum |
Unknown status |
NCT02199925 |
Phase 4 |
Gammaplex 5% |
5 |
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism |
Completed |
NCT01337700 |
Phase 4 |
Milnacipran;Placebo |
6 |
Treatment of Childhood Regressive Autism With Minocycline: an Anti-Inflammatory Agent Active Within the CNS |
Completed |
NCT00409747 |
Phase 4 |
Minocycline |
7 |
Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder |
Completed |
NCT02096952 |
Phase 4 |
Methylphenidate extended-release liquid formulation |
8 |
Quillivant XR in Children With Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study |
Completed |
NCT02255565 |
Phase 4 |
Very Low Dose Quillivant XR;Low Dose Quillivant XR;Moderate Dose Quillivant XR |
9 |
The Role of Omega-3 Fatty Acids in the Management of Singaporean Children With Autism Spectrum Disorders |
Completed |
NCT01695200 |
Phase 4 |
|
10 |
Atomoxetine, Placebo and Parent Management Training in Autism |
Completed |
NCT00844753 |
Phase 4 |
atomoxetine;Placebo |
11 |
A Randomized, Double-blind Comparison of Atomoxetine Hydrochloride and Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder |
Completed |
NCT00380692 |
Phase 4 |
Atomoxetine;Placebo |
12 |
Pilot Study of the Effect of Aripiprazole Treatment in Autism Spectrum Disorders on Functional Magnetic Resonance Imaging (fMRI) Activation Patterns and Symptoms |
Completed |
NCT01028820 |
Phase 4 |
Aripiprazole |
13 |
Improving Driving in Young People With Autism Spectrum Disorders |
Completed |
NCT03538431 |
Phase 4 |
Buspirone |
14 |
Divalproex Sodium ER in Adult Autism |
Completed |
NCT00211796 |
Phase 4 |
Divalproex Sodium ER |
15 |
Oxytocin-based Pharmacotherapy for Autism Spectrum Disorders: Investigating the Neural and Behavioral Effects of a Promising Intervention Approach |
Completed |
NCT02940574 |
Phase 4 |
Syntocinon (Oxytocin) |
16 |
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders |
Completed |
NCT01333865 |
Phase 4 |
Memantine |
17 |
Multisite Study: Acquisition of Social Skills in Children With Autism Using Video Modeling in Parental Training |
Completed |
NCT02235467 |
Phase 4 |
|
18 |
Biomarkers in Autism of Aripiprazole and Risperidone Treatment |
Completed |
NCT01333072 |
Phase 4 |
Aripiprazole;Risperidone |
19 |
A Prospective Open-label Trial of Metformin for Weight Control of Pediatric Patients on Atypical Antipsychotic Medications. |
Completed |
NCT00391261 |
Phase 4 |
Metformin |
20 |
Risperidone in the Treatment of Children and Adolescents With Autistic Disorder: A Double-Blind, Placebo-Controlled Study of Efficacy and Safety, Followed by an Open-Label Extension Study of Safety |
Completed |
NCT00576732 |
Phase 4 |
Placebo;Risperidone high dose;Risperidone low dose |
21 |
Metabolic Effects of Antipsychotics in Children |
Completed |
NCT00205699 |
Phase 4 |
risperidone;olanzapine;aripiprazole |
22 |
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder |
Completed |
NCT01238575 |
Phase 4 |
extended-release guanfacine |
23 |
Safety and Efficacy of Aripiprazole in the Long-term Maintenance Treatment of Pediatric Patients With Irritability Associated With Autistic Disorder |
Completed |
NCT01227668 |
Phase 4 |
Aripiprazole;Placebo |
24 |
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs |
Completed |
NCT01050582 |
Phase 4 |
Risperidone;Other atypical antipsychotic drugs |
25 |
An Open Label Pilot Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behavior Problems in Children and Adolescents With Autistic Spectrum Disorders |
Completed |
NCT00485849 |
Phase 4 |
Atomoxetine Hydrochloride |
26 |
An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) |
Recruiting |
NCT03757585 |
Phase 4 |
Open-label Treatment with Omega-3 Fatty Acids + Inositol;Open-label Treatment with N-acetylcysteine |
27 |
Biomarker-Driven Pharmacological Treatment for Autism Spectrum Disorder |
Recruiting |
NCT05063656 |
Phase 4 |
Gabapentin |
28 |
A Multi-Center, Open Label, Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder |
Recruiting |
NCT03337646 |
Phase 4 |
Lisdexamfetamine Dimesylate |
29 |
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole |
Recruiting |
NCT04903353 |
Phase 4 |
Comparison of Risperidone and Aripiprazole |
30 |
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT |
Recruiting |
NCT05146245 |
Phase 4 |
|
31 |
Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes |
Enrolling by invitation |
NCT03333629 |
Phase 4 |
|
32 |
Controlled-Release Melatonin (Melatonin CR)for the Treatment of Impaired Sleep Maintenance (ISM) in 4-8 Year Old Children With Autism Spectrum Disorders (ASD). |
Terminated |
NCT01033565 |
Phase 4 |
Natrol |
33 |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Trial of Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder |
Unknown status |
NCT04174365 |
Phase 3 |
Brexpiprazole;Placebo |
34 |
A Phase 3, Multicenter, Open Label Trial to Evaluate the Long-term Safety and Tolerability of Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder |
Unknown status |
NCT04258839 |
Phase 3 |
Brexpiprazole |
35 |
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex |
Unknown status |
NCT01730209 |
Phase 2, Phase 3 |
Everolimus;Placebo |
36 |
Valproate Response in Aggressive Autistic Adolescents |
Unknown status |
NCT00065884 |
Phase 3 |
Valproate |
37 |
Group Psychoeducational Program for Mothers of Preschool Children With High Functional Pervasive Developmental Disorders: a Randomized Controlled Trial |
Unknown status |
NCT01243905 |
Phase 2, Phase 3 |
|
38 |
Targeted Pharmacologic Interventions for Autism: A Double-Blind, Placebo-Controlled Trial of Atomoxetine in Children and Adolescents With Autism |
Completed |
NCT00498173 |
Phase 3 |
Atomoxetine;Placebo |
39 |
Galantamine Versus Placebo in Childhood Autism |
Completed |
NCT00252603 |
Phase 3 |
Galantamine |
40 |
Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders - |
Completed |
NCT02757066 |
Phase 2, Phase 3 |
NPC-15 Granules Lower Dose;NPC-15 Granules Higher Dose;NPC-15 Placebo Granule |
41 |
A Prospective, Open-Label Study of Paliperidone ER in Adolescents and Young Adults With Autism |
Completed |
NCT00549562 |
Phase 3 |
Paliperidone ER |
42 |
An Examination of Changes in Urinary Metabolites With Use of Folinic Acid in Children With Autism Spectrum Disorder (ASD) |
Completed |
NCT03771560 |
Phase 2, Phase 3 |
folinic acid |
43 |
Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder |
Completed |
NCT01972074 |
Phase 3 |
Memantine |
44 |
A Double-Blind Placebo-Controlled Randomized Clinical Trial of Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood? |
Completed |
NCT00655174 |
Phase 3 |
fluvoxamine;sertraline;Placebo |
45 |
Phase III Study of Autism Co-Morbid for Attention Deficit Hyperactivity Disorder |
Completed |
NCT00541346 |
Phase 3 |
Methylphenidate Transdermal System |
46 |
Study Of Fluoxetine In Autism: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group 14-Week Study To Investigate The Effect Of Fluoxetine Orally Dissolving Tablet (ODT) On Repetitive Behaviors In Childhood And Adolescent Autistic Disorder. |
Completed |
NCT00515320 |
Phase 3 |
Fluoxetine;Placebo |
47 |
An Examination of Changes in Urinary Metabolites With Use of an Antioxidant Supplement, Sulforaphane, in School-aged Children With Autism |
Completed |
NCT02654743 |
Phase 3 |
|
48 |
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD) |
Completed |
NCT03015272 |
Phase 2, Phase 3 |
|
49 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism |
Completed |
NCT00036244 |
Phase 3 |
RG1068 (Synthetic Human Secretin) |
50 |
Supporting the Well Being of Families of Young Children With Autism Spectrum |
Completed |
NCT01021384 |
Phase 3 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Fenfluramine
Fenfluramine Hydrochloride
quetiapine
Quetiapine fumarate
|
Risperidone
venlafaxine
Venlafaxine hydrochloride
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Autism:
Embryonic/Adult Cultured Cells Related to Autism:
|